Sharps Disposal Plan for Janssen Biotech, Inc. (Janssen) Janssen Biotech, Inc. is a Johnson - Janssen - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-01-16 10:51:28 Medical equipment Medical ethics Immunosuppressants Monoclonal antibodies Ustekinumab Golimumab Johnson & Johnson Medical waste Stericycle Medicine Centocor Pharmacology		Sharps Disposal Plan for Janssen Biotech, Inc. (Janssen) Janssen Biotech, Inc. is a Johnson & Johnson (J&J) company. J&J is committed to the health and wellbeing of families everywhere. Our commitment is evident in the v Add to Reading List Source URL: www.janssenbiotech.com Download Document from Source Website File Size: 156,79 KB Share Document on Facebook

	Rheumatoid Arthritis PhysioLab® Therapies Adalimumab Infliximab Golimumab DocID: 19erG - View Document
	6.5 Golimumab, 50 mg/0.5 mL injection, 1x 0.5 mL, syringe Simponi®; Infliximab, 100 mg injection, 1x 100 mg vial, Remicade®; Ustekinumab 45 mg/0.5 ml injection, 1x 0.5 ml vial, DocID: 193OM - View Document
	Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that DocID: 178k2 - View Document
	PDF Document DocID: 16aNt - View Document
	SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medici DocID: 15UGr - View Document